Patients or caregivers must give electronic consent when signing up for OmniSource patient support services. By completing the electronic consent form, patients are authorizing the release of personal health information.
Omnitrope Co-Pay Savings Program Eligibility:
The Omnitrope Co-Pay Savings Program provides up to $5000 in annual Co-Pay support for Omnitrope prescriptions. With the Omnitrope Co-Pay Savings Program, eligible patients may pay $0 for their Co-Pay. Eligible patients who are commercially insured may receive Co-Pay support in the amount of up to $5000 annually, and patients who are uninsured may receive Co-Pay support in the amount of up to $417 monthly, with an annual cap of $5000. Prescription must be for an approved indication. This program is not health insurance. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DoD, or TRICARE, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Patients can participate for a maximum of 12 months. Eligible patients must have a first use of the program by December 31 of the current year. Omnitrope Co-Pay Savings Program may not be combined with any other rebate, coupon, or offer. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice. Omnitrope Co-Pay Savings Program has no cash value.
Omnitrope® is a recombinant human growth hormone indicated for: